Drug
Ivosidenib Azacitidine
Ivosidenib Azacitidine: highest development phase Phase 2, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ivosidenib + oral azacitidine NCT07463768 | Phase 2 | Acute Myeloid Leukemia |
Latest
No recent events.
Follow Ivosidenib Azacitidine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.